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Despite the high prevalence of hypertension (HTN), only a small proportion of the hyper-
tensive patients will ultimately develop hypertensive crisis. In fact, some patients with 
hypertensive crisis do not report a history of HTN or previous use of antihypertensive 
medication. The majority of the patients with hypertensive crisis often report non-specific 
symptoms, whereas heart-related symptoms (dyspnea, chest pain, arrhythmias, and 
syncope) are less common. Hypertensive crises can be divided into hypertensive emer-
gencies or hypertensive urgencies according to the presence or absence of acute target 
organ damage, respectively. This differentiation is an extremely useful classification in 
clinical practice since a different management is needed, which in turn has a significant 
effect on the morbidity and mortality of these patients. Therefore, it is very crucial for the 
physician in the emergency department to identify the hypertensive emergencies and 
to manage them through blood pressure lowering medications in order to avoid further 
target organ damage or deterioration. The aim of this narrative review is to summarize 
the recent evidence in an effort to improve the awareness, recognition, risk stratification, 
and treatment of hypertensive crisis in patients referred to the emergency department.
Keywords: hypertensive crisis, management, hypertensive emergencies, hypertensive urgencies, hypertension
inTRODUCTiOn
Systemic hypertension (HTN) is the most common chronic medical disorder affecting over 1 bil-
lion people worldwide and more than 65 million adults in the Unites States (1). Worldwide, recent 
estimations indicate that HTN is the responsible cause for approximately 7.1 million deaths per year 
(2). In addition to this, HTN is one of the most frequent causes of visit to the physician’s office (3). 
Among the HTN population, about 1–2% of the patients will ultimately develop hypertensive crisis, 
which according to the 2003 Joint National Committee (JNC) on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure (JNC 7) is defined as the elevation of systolic blood pressure 
(SBP) >179 mmHg or diastolic blood pressure (DBP) >109 mmHg (4). Hypertensive crises can be 
divided further into hypertensive emergencies or hypertensive urgencies according to the presence or 
absence of acute target organ damage, respectively. Target organ damage can be defined as the acute 
damage and resulting dysfunction of the eyes (fundoscopy findings, such as hemorrhages, exudates, 
or papilledema), the brain (hypertensive encephalopathy), the heart (acute pulmonary edema), or 
the kidneys (acute renal failure). This differentiation is an extremely useful entity in clinical practice 
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given that a different management is needed, which in turn has 
significant effect on the morbidity and mortality of these patients. 
More specifically, in hypertensive urgencies, the blood pressure 
(BP) should be reduced within 24–48  h, whereas hypertensive 
emergencies require immediate BP reduction in order to prevent 
irreversible target organ damage (2). However, despite this 
distinction, a patient presenting with hypertensive urgency may 
have history of previous end-organ damage and chronic HTN 
without ongoing or imminent target organ dysfunction (2, 5).
The aim of this narrative review is to summarize the recent 
evidence in an effort to improve the awareness, recognition, risk 
stratification, and treatment of hypertensive crisis in patients 
referred to the emergency department.
ePiDeMiOLOGY AnD CLiniCAL PROFiLe
In a recent large multicenter Italian study (6), 4.6/1,000 cases—
out of 333,407 patients—consecutively admitted to emergency 
department were diagnosed with hypertensive crises (n = 1,546). 
Out of 1,546 hypertensive cases, 25.3% of them (n = 391) being 
reported as hypertensive emergencies. Interestingly, 23% of the 
emergencies occurred in patients with unknown HTN (27.9% 
among men and 18.5% among women). Regarding symptoms, 
the majority (55.6%) of the hypertensive crisis patients reported 
non-specific symptoms like headache without neurological defi-
cit, dizziness, vomits, palpitations, etc., even among emergency 
cases (49.3%). Moreover, heart-related symptoms (dyspnea, chest 
pain, arrhythmias, and syncope) were the less common symptoms 
in hypertensive crises (28.3%). Regarding hypertensive emergen-
cies, the majority (30.9%) of the patients had acute pulmonary 
edema, 22% had stroke, and 17.9% had myocardial infarction. 
Less frequent diagnoses were acute aortic dissection (7.9%), 
acute renal failure, and hypertensive encephalopathy (4.9%). 
Also, patients with hypertensive emergencies had 34% higher 
odds of being male and 28% less odds of having non-specific 
symptoms compared with patients with hypertensive urgencies. 
The importance of this study was that the frequency of unknown 
HTN both in the hypertensive crises and more specifically in 
the hypertensive emergencies was higher compared to previous 
studies published in the literature.
Regarding the clinical profile of the patients presenting with 
hypertensive crises, a recent cross-sectional study in Brazil (7) 
revealed that about 88% of the patients with hypertensive crisis 
reported known history of HTN, whereas approximately 76% of 
the patients were treated previously with antihypertensive treat-
ment. Patients presenting with hypertensive emergency were 
older (63.4 ± 13.4 vs. 57.0 ± 15.6, p < 0.001), more sedentary, 
and antihypertensive medication were less frequently prescribed 
compared to those with hypertensive urgency, whereas no other 
differences were found in terms of other cardiovascular risk fac-
tors, like smoking or prevalence of diabetes mellitus.
Different symptoms and clinical profile have been reported in 
studies comparing hypertensive emergencies and urgencies. More 
specifically, age and diastolic pressure were higher in hyperten-
sive emergencies than hypertensive urgencies. The most frequent 
sign and symptom in hypertensive urgency was headache (22%) 
and chest pain (27%) followed by dyspnea (22%) in hypertensive 
emergencies. End-organ damage in hypertensive emergencies 
was associated more frequently with cerebral infarction (24%), 
acute pulmonary edema (23%), and hypertensive encephalopathy 
(16%) (8). Similarly, in a recent study of 73,063 hypertensive 
patients presenting to the emergency room from 2005 to 2010, 
patients with hypertensive crisis were more frequently presented 
with headache and chest pain (9).
PATHOPHYSiOLOGY
The precise pathophysiology of the hypertensive crisis remains 
unclear. However, two different but interrelated mechanisms may 
play a central role in the pathophysiology of the hypertensive 
crisis. The first is the failure in autoregulatory mechanism in the 
vascular bed. The autoregulation system is a key factor in the 
pathophysiology of HTN and hypertensive crisis. Autoregulation 
is defined as the ability of the organs (brain, heart, and kidneys) to 
maintain a stable blood flow irrespective of alterations of perfu-
sion pressure. If the perfusion pressure drops, the corresponding 
blood flow decreases temporarily, but it returns to normal values 
after the next few minutes. In case of autoregulation malfunction, 
if the perfusion pressure drops, this leads to decrease in blood 
flow and an increase in vascular resistance. In hypertensive crisis, 
there is a lack of autoregulation in vascular bed and blood flow 
and so an abrupt increase of BP and systemic vascular resistance 
can occur, which often leads to mechanical stress and endothelial 
injury (10).
The second mechanism is the activation of renin–angiotensin 
system, leading to further vasoconstriction and thus generating a 
vicious cycle of continuous injury and subsequently ischemia (2). 
Besides these mechanisms, a prothrombotic state may play a key 
role in hypertensive crisis; a recent, albeit small, study showed that 
sP-selectin was significantly higher in patients with hypertensive 
crisis compared with normotensive controls regardless of the 
presence of retinopathy, which suggests that platelet activation 
is a relatively early finding in the pathophysiologic sequelae of 
hypertensive crisis (11) (Figure 1).
DiAGnOSiS
The evaluation of a hypertensive crisis initially includes a detailed 
medical history. More specifically, the physician should ask the 
patient about (i) the duration of HTN history, (ii) any evidence 
of uncontrolled BP recordings in the past, (iii) concomitant 
administration of other drugs that might increase BP (e.g., non-
steroidal anti-inflammatory drugs), (iv) history of sleep apnea 
syndrome, and (v) evaluation of cardiovascular risk factors and 
other comorbidities.
Also, physical examination should include (i) auscultation of 
heart sounds/murmurs (aortic coarctation), neck arteries, and 
abdominal murmurs, (ii) neurological deficits, (iii) fundoscopy 
to assess for retinopathy, grade III (flame hemorrhages, dot 
and blot hemorrhages, hard and soft exudates), or grade IV 
(papilledema), (iv) absence, reduction, or asymmetry of pulses 
in the lower extremities, and (v) examination of the abdomen 
(aortic aneurysm). Also, vital signs should be checked carefully 
in the evaluation of a patient with hypertensive crisis, e.g., BP, 
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oxygen saturation, and heart rate. More specifically, BP should be 
measured in both the arms to detect any potential differences (2). 
In a recent study of 189 patients, normal heart rate was associated 
with hypertensive urgency, whereas patients with hypertensive 
emergency had higher average heart rate. Tachycardia was most 
associated with hypertensive left ventricular failure in the setting of 
hypertensive emergency due to activation of sympathetic nervous 
system. Moreover, heart rate less than 100 bpm had high specific-
ity, classifying patients as hypertensive urgencies. However, other 
hemodynamic parameters such as systolic or DBP and pulse 
pressure were not able to classify hypertensive emergencies from 
hypertensive urgencies (12). This vital sign seems to be useful in 
the emergency department in the differentiation of hypertensive 
emergencies from hypertensive urgencies.
Initial laboratory analyses should be performed rapidly 
after initial evaluation of the patient. These laboratory analyses 
include urinalysis (check for significant proteinuria, red blood 
cells, cellular casts, or analysis for metanephrines in case of high 
suspicion of pheochromocytoma), a chemistry panel (creatinine, 
blood urea nitrogen levels), electrocardiogram (to check for 
myocardial ischemia or infarction and/or signs of left ventricular 
hypertrophy), a plain chest radiograph (evaluation of cardio-
megaly or pulmonary edema), brain computed tomography (CT) 
scan (evaluation of neurological deficits), and chest CT scan or 
transesophageal echocardiography (in suspicion of aortic dissec-
tion) (2).
A fast transthoracic echocardiogram could be also useful to 
assess the function of the left ventricle to measure the ejection 
fraction or to detect segmental hypokinesias. Even if new echo-
cardiography imaging techniques are not used extensively in daily 
clinical practice, it seems that speckle-tracking echocardiography 
may detect depressions of global longitudinal left ventricular 
systolic strain and global systolic strain rate during hypertensive 
crisis as opposed to left ventricular ejection fraction (13). Despite 
this interesting finding, speckle tracking echocardiography is not 
easy to implement in an emergency department setting.
TReATMenT
It seems that patients with hypertensive crises, regardless of 
whether it is the emergency or urgency subtype, receive treatment 
mostly in a rather heterogeneous and empirical way. However, 
important treatment options are available to emergency depart-
ment physicians.
In cases with hypertensive urgency BP control should be 
managed with the use of low doses of oral antihypertensive 
medications, where a gradual decrease of BP over hours to days 
is expected. Medications that can be used to treat hypertensive 
urgencies are oral labetalol (3:1 ratio of antagonism of non-
selective β-adrenergic and a1 receptor) and clonidine (central 
a-2 agonist).
On the other hand, hypertensive emergencies require rapid 
BP control with a parenteral antihypertensive medication, and in 
these instances the patient should be admitted to intensive care 
unit. The BP should be reduced within minutes to an hour to about 
20–25% in the first hour and then to 160/100 or 160/110 mmHg 
within the next 2–6 h. However, BP should not be returned to 
normal values (14). This is due to the fact that additional BP 
reduction could cause brain ischemia due to abnormal cerebral 
flow autoregulation in these patients. An exception to this would 
be in the case of aortic dissection, where the rapid and immedi-
ate reduction of BP within 5–10 min using initially a parenteral 
β-blocker (i.e., esmolol) (BP target: SBP <120 mmHg and a mean 
arterial pressure <80 mmHg) is crucial for the patient (14, 15).
A great number of medications are available for the treatment 
of hypertensive emergencies. Sodium nitroprusside is a first-
choice for the majority of hypertensive emergencies, and it acts 
within seconds as a potent arterial and venous dilator. The most 
important disadvantage is thiocyanate toxicity. The toxicity is 
more likely to occur if patients have hepatic or renal failure and 
when the agent is administered for more than 48–72 h (16).
Labetalol can be used to treat hypertensive emergencies 
through IV administration with a non-selective β-blocker and a1 
adrenergic receptor blocker with 6.9:1 ratio of antagonism reduc-
ing the systemic vascular resistance but maintaining the cerebral, 
renal, and coronary blood flow. It is interesting that despite the 
β-blocking effect it maintains also the cardiac output (2).
Nitroglycerine is a venodilator that mainly reduces the preload 
and decreases the cardiac oxygen demands, and it is often used 
in hypertensive crises. This agent is used primarily in acute myo-
cardial infarction and acute pulmonary edema along with other 
antihypertensive regimens (17).
Other agents that can be used in hypertensive emergencies 
include nicardipine (dihydropyridine calcium channel blocker), 
which is a useful agent for patients with coronary artery disease 
due to its beneficial effect on coronary blood flow or clevidipine, 
which is a new short-acting intravenous dihydropyridine calcium 
channel blocker (14). Enalaprilat is an angiotensin-converting 
enzyme inhibitor, but it is not recommended since it can aggra-
vate renal blood flow, and the potential of renal failure in patients 
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with hypertensive emergency is high (18, 19). Fenoldopam is an 
important medication, and it acts through peripheral dopamine-1 
receptors as a vasodilator and as a diuretic. It has been shown 
to be an effective and well-tolerated agent for the treatment of 
hypertensive emergency (20). Diuretics are not generally recom-
mended agents for the treatment of hypertensive emergencies 
with the exception of acute pulmonary edema. However, in 
a recent small randomized controlled trial (21), researchers 
randomized 59 patients with acute pulmonary edema due to 
hypertensive crisis to either furosemide or placebo. Researchers 
concluded that the subjective perception of dyspnea in patients 
with hypertensive pulmonary edema was not influenced by the 
administration of a loop-diuretic. This may be due to the fact 
that patients with hypertensive heart failure are often euvolemic 
or only mildly hypervolemic and also that loop-diuretics and 
especially furosemide after IV administration initially exert 
vasodilation of the venous capacitance.
PROGnOSiS
It seems that hypertensive emergencies have different prognoses 
compared to hypertensive urgencies. Due to the fact that several 
medications can be used to treat hypertensive crises, epidemio-
logical data show that the mortality of the hypertensive emer-
gency has been decreased gradually from 80% in 1928 to 10% 
in 1989 (22). In a recent study with hypertensive crisis patients 
who were admitted to a coronary care unit, researchers found 
that the overall mortality was 3.7%. In patients with hypertensive 
emergency, the mortality was higher (4.6%) compared with 
patients with hypertensive urgencies (0.8%) (23). Despite the 
different prognosis between patients with two entities, other 
researchers tried to find prognostic factors of major adverse car-
diac or cerebrovascular events (MACCE) defined as a composite 
of myocardial infarction, unstable angina, hypertensive crisis, 
pulmonary edema, stroke, or transient ischemic attack. In a 
recent retrospective study with a 2-year duration, patients with 
hypertensive crises and elevated cardiac troponin-I (c TnI) had 
2.7 times higher risk for the occurrence of MACCE at 2-years 
follow-up compared with those with normal c TnI values (24). 
The introduction of a prognostic score from large epidemiologi-
cal studies could be of high value in order to stratify the patients 
according to baseline clinical and demographic characteristics.
COnCLUSiOn
Hypertensive crisis has the potential of end-organ damage, and 
this has a significant effect on patient’s prognosis. The prognosis 
differs substantially whether the patient is presenting with hyper-
tensive emergency or urgency. Several regimens are effective to 
treat both hypertensive emergencies and urgencies, but the choice 
of the treatment is dependent on the clinical presentation of the 
patient. It is very crucial for the physician in the emergency 
department to identify the hypertensive emergencies quickly and 
so to intervene with BP-lowering medications in order to avoid 
further target organ damage and deterioration.
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